SCHEMBL8056830

SCHEMBL8056830

C1CNC2C[N]CCC2C1

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 2/20 0.33
EPAS1 Q99814 1/20 0.32
MBTD1 Q05BQ5 1/20 0.31
L3MBTL3 Q96JM7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8062474 0.94 EPAS1 (0.34) HRH4EPAS1
SCHEMBL1384760 0.86
SCHEMBL7856396 0.84 EPAS1 (0.32) EPAS1
SCHEMBL7854722 0.84
SCHEMBL7854501 0.83 EPAS1 (0.32) EPAS1
SCHEMBL7852425 0.83 EPAS1 (0.32) EPAS1
SCHEMBL6486136 0.83 EPAS1 (0.32) EPAS1MBTD1L3MBTL3
SCHEMBL7854119 0.83 EPAS1 (0.32) EPAS1
SCHEMBL3204034 0.82
SCHEMBL477174 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6140333-A FOR TREATMENT AND/OR PROPHYLAXIS OF DISEASES INCLUDE SUCH RESPIRATORY DISEASES AS CHRONIC OBSTRUCTIVE PULMONARY DISEASES, CHRONIC BRONCHITIS, ASTHMA, CHRONIC RESPIRATORY OBSTRUCTION, PULMONARY FIBROSIS, PULMONARY EMPHYSEMA BANYU PHARMACEUTICAL CO LTD (JP) 2000-10-31 US disclosed